StemRegenin-1

StemRegenin-1 · Masonic Cancer Center, University of Minnesota

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for StemRegenin-1, covering 2017-12-05 to 2017-12-05. Get the full timeline:

Most recent: Clinical Trial Update: StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies [Phase 2]